Figure 1 shows the consistency between the model and data across the eight trials which employed both single and multiple doses of marketed semaglutide with a drug product strength of 1.34 mg/mL
About 1.7% of people in the US have been prescribed a semaglutide medication in 2023, up 40-fold over the past five years, according to data shared exclusively with CNN by Epic Research that was based on an analysis of millions of electronic health records
Web References : University of Colorado Anschutz: Fertility and Sterility Journal Article: RESTORE Clinical Trial: References : DOI: 10.1016/j.fertnstert.2026.06.002 Keywords : PMOS, polyendocrine metabolic ovarian syndrome, PCOS, semaglutide, GLP-1 receptor agonist, reproductive health, metabolic dysfunction, obesity, infertility, ovulation restoration, RESTORE trial, endocrine disorder
They are not intended for human or veterinary consumption, and we make no therapeutic, diagnostic, or clinical claims
In fact, studies on GLP-1 receptor agonists (like semaglutide) suggest that these drugs may help improve testosterone levels in men who are obese or have type 2 diabetes [4]